0001185185-26-000588
SEC filingAnbio Biotechnology filed a Form 6-K on February 17, 2026, attaching Exhibit 16.1, a letter from HTL International, LLC confirming agreement with statements concerning their firm in the filing. HTL International, LLC does not agree or disagree with other statements in the Form 6-K.